Shire Plc reported revenue of $1.1 billion in the second quarter of 2011, up by 25% from a year earlier on increased sales of products for rare diseases and for attention deficit hyperactivity disorder (ADHD). GAAP operating income was $283 million. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
